Remove tag prime-medicine
article thumbnail

Grand Rounds December 8, 2023: A Pragmatic Randomized Trial of the Jumpstart Intervention to Promote Communication about Goals of Care for Hospitalized Patients with Serious Illness (Ruth Engelberg, PhD; Erin Kross, MD; Robert Lee, MD, MS)

Rethinking Clinical Trials

The Jumpstart intervention is a communication-priming intervention. The research question Jumpstart set out to answer is can a patient-specific, clinician-facing communication priming intervention with discussion prompts effectively promote goals of care discussions between clinicians and hospitalized older adults with serious illness?

Trials 130
article thumbnail

WHY PM MODI ADDRESSED, INDIA AS THE PHARMACY OF THE WORLD

Pharma Tutor

Recently, during inauguration of Global Innovation Summit of the pharmaceuticals sector Indian Prime Minister Shri Narendra Modi addressed, India as the Pharmacy of the world. We have exported life-saving medicines and medical equipment to over 150 countries during the initial phase of the pandemic. Fri, 11/19/2021 - 16:19.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Scientists turn cancer cells into anticancer agents

Drug Discovery World

The findings are published in Science Translational Medicine. . The engineered tumour cells were also designed to express factors that would make it easy for the immune system to spot, tag, and remember them, priming the immune system for a long-term antitumour response. .

article thumbnail

J&J gets first approval for multiple myeloma bispecific Tecvayli

pharmaphorum

Tecvayli previously scored a priority medicines (PRiME) designation from the EMA and a breakthrough-therapy tag from the FDA. A marketing application for teclistamab is also under review at the FDA, with a decision expected later this month or in early September.

article thumbnail

CHMP backs J&J’s myeloma bispecific Tecvayli, ahead of US decision

pharmaphorum

The EMA’s human medicines committee has recommended approval of Johnson & Johnson’s Tecvayli as a fourth-line therapy for multiple myeloma , joining a growing group of BCMA-targeted therapies for the blood cancer.

article thumbnail

A history of Pfizer

pharmaphorum

After the war, Pfizer continued to focus on industrial chemicals as much as medicines, producing the citric acid needed for the emerging soft drinks industry, fuelling brands like Coca Cola and Dr Pepper’s expansion in the 1880s. Pfizer seemed unable to allay the concerns of prime minister David Cameron and business secretary Vince Cable.

Sales 127
article thumbnail

AAIC 2021: Six Ways the Approval of Aducanumab Will Change Alzheimer’s Clinical Trials

XTalks

This is not a debate on approval,” said Stacie Weninger, PhD, president of the F-Prime Biomedical Research Initiative, in a focused topic session on the impact of drug approval on future clinical trials held on Tuesday July 27. Grill, PhD, a professor of psychiatry and human behavior in the School of Medicine at UC Irvine.